ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	IRCT
Last refreshed on:	22 February 2018
Main ID:	IRCT2012111111430N1
Date of registration:	2013-04-17
Prospective Registration:	Yes
Primary sponsor:	Reaserch center of Avicenna
Public title:	The effect of decapeptile on treatment of infertile women in ICSI(Intracytoplasmic Sperm Injection) cycles
Scientific title:	Efficacy of gonadotropin-releasing hormone agonist addition for luteal phase support in women with repeated implantation failure undergoing intracytoplasmic sperm injection cycles
Date of first enrolment:	2013-04-21
Target sample size:	100
Recruitment status:	Complete
URL:	http://en.irct.ir/trial/11700
Study type:	interventional
Study design:	Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
Phase:	3

Countries of recruitment
Iran (Islamic Republic of)

Contacts

Name:	Simin.Zafardoust
Address:	Shariaty-Yakhchal 19419113194 Tehran Iran (Islamic Republic of)
Telephone:	+98 21 2264 4701
Email:	siminzafardoost@yahoo.com
Affiliation:	Infertility and recurrent pregnancy loss center of Avecinna

Name:	Zafardoust Simin M.D
Address:	Yakhchal-Shriati 19419113194 Tehran Iran (Islamic Republic of)
Telephone:	+98 21 2264 4701
Email:	siminzafardoost@yahoo.com
Affiliation:	Infertility and recurrent pregnancy loss center of Avecinna

Key inclusion & exclusion criteria

Inclusion criteria: Inclusion: couples with two or more IVF Failure with good quality embryo transfer; women with antagonist cycle; women with at least one embryo for transfer; women under IVF wiht ones gamet and women under 42 years.
Exclusion criteria: cycles with preimplantation genetic diagnosis; women with anatomical uterine disorders or hydrosalpinx and women with thyroid disorders.
Exclusion criteria:

Age minimum: no limit
Age maximum: 42 years
Gender: Female

Health Condition(s) or Problem(s) studied

Infertility.
Female infertility, unspecified

Female infertility, unspecified

Intervention(s)

There is no intervention in control group

Treatment - Drugs

Intervention 1: Six days after ovum pick up single dose of 0.1 mg Decapeptile-S.C (Intervention group). Intervention 2: There is no intervention in control group.

Six days after ovum pick up single dose of 0.1 mg Decapeptile-S.C (Intervention group)

Primary Outcome(s)

Pregnancy. Timepoint: Ten days, 3 weeks, 3 months and 5 months after. Method of measurement: HCG, sonography, follow up.

Secondary Outcome(s)

Twin pregnancy. Timepoint: Vaginal ultrasonography in 6-8 weeks. Method of measurement: Number of gestational sacs.

Abortion. Timepoint: every 3 months. Method of measurement: sonography-follow up.

Secondary ID(s)

Source(s) of Monetary Support

Reaserch center of Avicenna

Secondary Sponsor(s)

Ethics review

Status: Approved
Approval date:
Contact:

Reasearch center of Jahad-Avicenna

Results

Results available:	Yes
Date Posted:
Date Completed:
URL:	Effect of Administration of Single Dose GnRH Agonist in Luteal Phase on Outcome of ICSI-ET Cycles in Women with Previous History of IVF/ICSI Failure: A Randomized Controlled Trial

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.